Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cryosurgery | 2 | 2024 | 36 | 1.050 |
Why?
|
| Lymphography | 1 | 2025 | 10 | 0.960 |
Why?
|
| Lymphatic Diseases | 1 | 2025 | 22 | 0.940 |
Why?
|
| Seminal Vesicles | 1 | 2024 | 13 | 0.900 |
Why?
|
| Radiopharmaceuticals | 1 | 2024 | 204 | 0.810 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2024 | 188 | 0.800 |
Why?
|
| Child | 14 | 2025 | 7248 | 0.800 |
Why?
|
| Ureter | 1 | 2022 | 36 | 0.760 |
Why?
|
| Positron-Emission Tomography | 1 | 2024 | 301 | 0.750 |
Why?
|
| Central Venous Catheters | 1 | 2022 | 27 | 0.750 |
Why?
|
| Catheterization, Peripheral | 1 | 2022 | 49 | 0.750 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2021 | 14 | 0.720 |
Why?
|
| Catheterization, Central Venous | 1 | 2022 | 84 | 0.710 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 1546 | 0.710 |
Why?
|
| Spinal Fusion | 1 | 2021 | 72 | 0.690 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 1 | 2019 | 3 | 0.660 |
Why?
|
| Foreign-Body Migration | 1 | 2019 | 31 | 0.640 |
Why?
|
| Device Removal | 1 | 2019 | 82 | 0.610 |
Why?
|
| Embolization, Therapeutic | 1 | 2019 | 88 | 0.600 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 86 | 0.590 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 636 | 0.560 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 178 | 0.530 |
Why?
|
| Retrospective Studies | 7 | 2024 | 6607 | 0.480 |
Why?
|
| Adolescent | 6 | 2024 | 6739 | 0.420 |
Why?
|
| Contrast Media | 2 | 2025 | 193 | 0.410 |
Why?
|
| Humans | 17 | 2025 | 52483 | 0.350 |
Why?
|
| Child, Preschool | 4 | 2024 | 4076 | 0.290 |
Why?
|
| Wolffian Ducts | 1 | 2024 | 2 | 0.230 |
Why?
|
| Cysts | 1 | 2024 | 51 | 0.220 |
Why?
|
| Image Enhancement | 1 | 2024 | 52 | 0.220 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2025 | 85 | 0.210 |
Why?
|
| Organometallic Compounds | 1 | 2024 | 43 | 0.210 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2023 | 25 | 0.210 |
Why?
|
| Diagnosis, Differential | 2 | 2024 | 1046 | 0.210 |
Why?
|
| Syndrome | 1 | 2024 | 247 | 0.210 |
Why?
|
| Radiology, Interventional | 1 | 2023 | 28 | 0.200 |
Why?
|
| Treatment Outcome | 3 | 2024 | 5422 | 0.200 |
Why?
|
| Male | 8 | 2024 | 26761 | 0.200 |
Why?
|
| Abnormalities, Multiple | 1 | 2024 | 166 | 0.200 |
Why?
|
| Diagnostic Imaging | 1 | 2024 | 181 | 0.200 |
Why?
|
| Dilatation, Pathologic | 1 | 2022 | 26 | 0.190 |
Why?
|
| Thymus Neoplasms | 1 | 2022 | 17 | 0.190 |
Why?
|
| Mediastinal Neoplasms | 1 | 2022 | 18 | 0.190 |
Why?
|
| Catheters, Indwelling | 1 | 2022 | 58 | 0.190 |
Why?
|
| Injections, Spinal | 1 | 2021 | 21 | 0.180 |
Why?
|
| Catheters | 1 | 2021 | 36 | 0.180 |
Why?
|
| Pleural Diseases | 1 | 2021 | 11 | 0.180 |
Why?
|
| Pneumothorax | 1 | 2021 | 20 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2023 | 1165 | 0.180 |
Why?
|
| Echo-Planar Imaging | 1 | 2020 | 11 | 0.180 |
Why?
|
| Oligonucleotides | 1 | 2021 | 76 | 0.180 |
Why?
|
| Disease Progression | 1 | 2023 | 871 | 0.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2020 | 133 | 0.160 |
Why?
|
| Lung | 1 | 2023 | 509 | 0.160 |
Why?
|
| Physicians | 1 | 2023 | 241 | 0.160 |
Why?
|
| Female | 5 | 2024 | 28171 | 0.130 |
Why?
|
| Kidney | 1 | 2020 | 707 | 0.130 |
Why?
|
| Infant | 1 | 2024 | 3733 | 0.120 |
Why?
|
| Abdominal Neoplasms | 1 | 2024 | 16 | 0.060 |
Why?
|
| Intestines | 1 | 2025 | 154 | 0.050 |
Why?
|
| Myositis | 1 | 2023 | 20 | 0.050 |
Why?
|
| Abdomen | 1 | 2024 | 75 | 0.050 |
Why?
|
| Radiography, Thoracic | 1 | 2023 | 67 | 0.050 |
Why?
|
| Physical Examination | 1 | 2024 | 99 | 0.050 |
Why?
|
| Mediastinum | 1 | 2022 | 21 | 0.050 |
Why?
|
| Public Opinion | 1 | 2022 | 21 | 0.050 |
Why?
|
| Adult | 3 | 2023 | 14161 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2024 | 430 | 0.050 |
Why?
|
| Inpatients | 1 | 2023 | 205 | 0.050 |
Why?
|
| Pneumonia, Staphylococcal | 1 | 2021 | 6 | 0.050 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2021 | 12 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2024 | 891 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2024 | 721 | 0.050 |
Why?
|
| Motion | 1 | 2020 | 19 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2023 | 292 | 0.040 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 82 | 0.040 |
Why?
|
| Intubation, Intratracheal | 1 | 2021 | 122 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1229 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 2481 | 0.030 |
Why?
|
| Young Adult | 1 | 2024 | 4329 | 0.030 |
Why?
|
| Middle Aged | 1 | 2023 | 13028 | 0.020 |
Why?
|